BioCryst Pharma's ORLADEYO leads HAE market growth, with strong financial performance and potential despite rising ...

ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for ...

Doctor-Formulated Blend of Resveratrol, Ashwagandha, and Telomere-Supportive Botanicals Aims to Enhance Cellular Energy, ...